Monitoring antimicrobial therapy.
D000328:Adult; D000617:Aminoglycosides / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000097:blood; D001219:Aspartate Aminotransferases / Q000032:analysis; D001770:Blood Bactericidal Activity; D001772:Blood Cell Count; D001799:Blood Sedimentation; D001855:Bone Marrow Diseases / Q000139:chemically induced; D002675:Child, Preschool; D003875:Drug Eruptions / Q000209:etiology; D004892:Erythema Multiforme / Q000139:chemically induced; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects; D007674:Kidney Diseases / Q000139:chemically induced; D008875:Middle Aged; D008991:Monitoring, Physiologic; D009582:Nitrofurantoin / Q000009:adverse effects; D010038:Otorhinolaryngologic Diseases / Q000139:chemically induced; D011018:Pneumonia, Pneumococcal / Q000139:chemically induced; D014581:Urticaria / Q000139:chemically induced
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D009582:Nitrofurantoin; D001219:Aspartate Aminotransferases; D007538:Isoniazid